C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis

Keywords

MedicineC-reactive proteinInternal medicineBody mass indexQuartileCardiologyHomocysteineSubclinical infectionFibrinogenProspective cohort studyRisk factorAspirinGastroenterologyStatinInflammationConfidence interval

Affiliated Institutions

Uniformed Services University of the Health Sciences US

Related Publications

Prospective Study of C-Reactive Protein, Homocysteine, and Plasma Lipid Levels as Predictors of Sudden Cardiac Death

Christine M. Albert , Jing Ma , Nader Rifai +2 more

Background — Sudden cardiac death (SCD) is an important cause of mortality even among apparently healthy populations. However, our ability to identify those at risk for SCD in t...

2002 Circulation 526 citations

Evaluating Novel Cardiovascular Risk Factors: Can We Better Predict Heart Attacks?

Paul M. Ridker

Myocardial infarction often occurs among persons without traditional risk factors, and it has been hypothesized that assessment of "novel" markers may help identify persons who ...

1999 Annals of Internal Medicine 332 citations

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Paul M. Ridker , Eleanor Danielson , Francisco Antônio Helfenstein Fonseca +11 more

In this trial of apparently healthy persons without hyperlipidemia but with elevated high-sensitivity C-reactive protein levels, rosuvastatin significantly reduced the incidence...

2008 New England Journal of Medicine 6445 citations

C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women

Paul M. Ridker , Charles H. Hennekens , Julie E. Buring +1 more

The addition of the measurement of C-reactive protein to screening based on lipid levels may provide an improved method of identifying persons at risk for cardiovascular events.

2000 New England Journal of Medicine 5763 citations

Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis

Steven E. Nissen , E. Murat Tuzcu , Paul Schoenhagen +10 more

For patients with coronary heart disease, intensive lipid-lowering treatment with atorvastatin reduced progression of coronary atherosclerosis compared with pravastatin. Compare...

2004 JAMA 2332 citations

Publication Info

Year: 2001
Type: article
Volume: 141
Issue: 2
Pages: 206-210
Citations: 127
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

127

OpenAlex

Cite This

APA Style

                            
                                
                                    Marc E. Hunt, 
                                
                                    Patrick G. O’Malley, 
                                
                                    Marina Vernalis
                                
                                et al.
                            
                            (2001). 
                            C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis. 
                            American Heart Journal
                            , 141
                            (2)
                            , 206-210.
                            https://doi.org/10.1067/mhj.2001.112488
                        

Identifiers

DOI: 10.1067/mhj.2001.112488